{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-008364","form_type":"8-K","ticker":"PURE","cik":"0001006028","company_name":"PURE BIOSCIENCE, INC.","filed_at":"2023-03-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:43.445656+00:00","generated_at":"2026-06-17T21:57:43.162570+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Pure Bioscience names Robert Bartlett CEO; Tom Lee resigns, stays on Board","bullets":["Tom Y. Lee resigned as President and CEO effective March 15, 2023; will continue on Board.","Robert Bartlett, Board member since Feb 2023, appointed President and CEO; base salary $300k, sign-on $17.5k.","Bartlett granted option to purchase 500k shares, vesting quarterly over one year.","Tom Myers transitioned from COO to EVP Technology and Development; remains on Board.","Kristin A. Taylor resigned from Board effective March 19, 2023; no disagreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-008364","json":"https://secwatch.observer/filing/0001493152-23-008364.json","markdown":"https://secwatch.observer/filing/0001493152-23-008364.md","text":"https://secwatch.observer/filing/0001493152-23-008364.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1006028/000149315223008364/0001493152-23-008364-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1006028/000149315223008364/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T21:57:43.162570+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1ccd621b47","claim":"Robert Bartlett was appointed as President and Chief Executive Officer at PURE BIOSCIENCE, INC..","evidence_excerpt":"the Board appointed Robert Bartlett, a member of the Board, as the Company’s President and Chief Executive Officer, effective as of the Effective Date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1006028/000149315223008364/0001493152-23-008364-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"28ade04971","claim":"Tom Myers departed as Executive Vice President, Technology and Development at PURE BIOSCIENCE, INC..","evidence_excerpt":"Tom Myers, the Company’s Chief Operating Officer and member of the Board, resigned as the Company’s Chief Operating Officer in connection with his transition to the Company’s Executive Vice President, Technology and Development, each effective as of the Effective Date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1006028/000149315223008364/0001493152-23-008364-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned as COO and transitioned to EVP"},{"label":"Role","value":"Executive Vice President, Technology and Development"}],"fact_type":"executive_change"},{"claim_id":"592be55447","claim":"Kristin A. Taylor resigned as Director at PURE BIOSCIENCE, INC..","evidence_excerpt":"On March 19, 2023, Kristin A. Taylor delivered notice to the Board of her resignation from the Board, effective March 19, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1006028/000149315223008364/0001493152-23-008364-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"e2bd48bff6","claim":"Tom Y. Lee resigned as President and Chief Executive Officer at PURE BIOSCIENCE, INC..","evidence_excerpt":"Tom Y. Lee, the President, Chief Executive Officer and member of the Board of Directors (the “Board”) of Pure Bioscience, Inc. (the “Company”), resigned as the Company’s President and Chief Executive Officer, effective as of the Effective Date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1006028/000149315223008364/0001493152-23-008364-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}